Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Scalp nerve block with liposomal versus standard bupivacaine for post-craniotomy pain relief

Official title: A Multicenter, Single-blind, Randomized Controlled Study on the Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Craniotomy

Run by Zhejiang University · NCT07049094 · Data updated 2026-11-12

This trial will test whether adding liposomal bupivacaine to scalp nerve blocks gives longer, better pain relief than standard bupivacaine for adults after elective craniotomy.

More Cerebrovascular Disease trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment218 (estimated)
SponsorZhejiang University
Academic / other
Locations1 site (Hangzhou, Zhejiang)
StatusRecruiting
StartedJune 25, 2025
Main results expectedJune 25, 2027
Study endsDecember 31, 2027
Registry record updatedJuly 3, 2025
Trial IDNCT07049094 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) scheduled for elective supratentorial craniotomy with ASA I–III, able to give informed consent, with preoperative GCS 15 and without significant preoperative headache or contraindications to nerve block are ideal candidates.

Probably not a fit

Patients with severe liver, renal, or heart failure, long-term opioid or steroid use, active infection or tumor at the puncture site, cognitive impairment, recent substance abuse, or preoperative headache NRS ≥4 are excluded and unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, single-blind, controlled Phase 4 trial at Zhejiang University compares standard hydrochloride bupivacaine scalp nerve blocks with a combination that includes liposomal bupivacaine in adults undergoing elective cranial surgery. Eligible patients are randomized to receive either standard bupivacaine or bupivacaine plus liposomal formulation, with clinicians aware of allocation and patients blinded. Outcomes include postoperative pain scores, opioid consumption, recovery quality, and complications, with thorough preoperative neurological and laboratory assessments. The protocol uses validated pain scales and standardized scalp nerve block techniques to measure analgesic duration and safety.

Why it matters

Potential benefit: If successful, this approach could provide longer-lasting post-craniotomy pain relief, reduce opioid use and opioid-related side effects, and help speed recovery.

How similar studies have gone: Scalp nerve blocks are an established part of multimodal analgesia after craniotomy, but use of liposomal bupivacaine for extended scalp analgesia has limited and mixed evidence in this specific setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* ASA I-III
* Scheduled for elective cranial surgery
* Informed consent from the patient or legal representative

Exclusion Criteria:

* Preoperative Glasgow score \< 15
* Preoperative headache with NRS ≥ 4
* Anticipated postoperative sedation or extubation difficulties requiring mechanical ventilation
* Inability to understand the numerical rating scale (NRS)
* Allergies or contraindications to amide local anesthetics, opioids, or NSAIDs
* Long-term opioid or corticosteroid treatment (\> 2 weeks)
* History of drug abuse in the past 2 years
* Daily alcohol consumption exceeding 3 standard doses
* Mental or cognitive disorders affecting perioperative assessment
* Contraindications for nerve blocks, including infection or tumors at the puncture site, diagnosed diabetic peripheral neuropathy, or inability to cooperate
* Severe liver dysfunction (Child-Pugh class C), severe renal dysfunction (requiring dialysis preoperatively), or severe heart failure (METS \< 4)
* Pregnant or breastfeeding women
* History of craniotomy or pre-existing pathological pain conditions (e.g., migraines, trigeminal neuralgia)
* Incisions for craniotomy extending beyond the area covered by the scalp nerve blocks
* Participation in other clinical trials

Where it's running

  • The First Affiliated Hospital, Zhejiang University School of Medicine
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.